ArticleAIDS (London, England)2018

Ex-vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV type 1 non-B subtypes.

Ujjwal Neogi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.